2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.

about

2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q48089791

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

2016 updated Thai Rheumatism A ...... nts with rheumatoid arthritis.

@en

2016 updated Thai Rheumatism A ...... nts with rheumatoid arthritis.

@nl

type

Item

label

2016 updated Thai Rheumatism A ...... nts with rheumatoid arthritis.

@en

2016 updated Thai Rheumatism A ...... nts with rheumatoid arthritis.

@nl

prefLabel

2016 updated Thai Rheumatism A ...... nts with rheumatoid arthritis.

@en

2016 updated Thai Rheumatism A ...... nts with rheumatoid arthritis.

@nl

P1476

2016 updated Thai Rheumatism A ...... ents with rheumatoid arthritis

@en

P2093

Ajanee Mahakkanukrauh

http://www.w3.org/2001/XMLSchema#string

Ajchara Koolvisoot

http://www.w3.org/2001/XMLSchema#string

Anawat Suesuwan

http://www.w3.org/2001/XMLSchema#string

Boonjing Siripaitoon

http://www.w3.org/2001/XMLSchema#string

Chayawee Muangchan

http://www.w3.org/2001/XMLSchema#string

Duangkamol Aiewruengsurat

http://www.w3.org/2001/XMLSchema#string

Kanokrut Nuntirooj

http://www.w3.org/2001/XMLSchema#string

Kitti Totemchokchyakarn

http://www.w3.org/2001/XMLSchema#string

Nuntana Kasitanon

http://www.w3.org/2001/XMLSchema#string

Paijit Asavatanabodee

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies

IgG placental transfer in healthy and pathological pregnancies

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic dr

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis.

P304

1166-1184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1756-185X.13130

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Worawit Louthrenoo

Pongthorn Narongroeknawin

Parawee Chevaisrakul

P577

2017-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28730640

http://www.w3.org/2001/XMLSchema#string

P921

An Téalainn